Microneedle coronavirus vaccine triggered immune response in mice
On Apr. 14, 2020, researchers from the University of Pittsburgh announced that they had adapted a system to…
Sanofi and GSK announced an unprecedented vaccine collaboration to fight COVID-19
On Apr. 14, 2020, Sanofi and GSK announced that they had signed a letter of intent to enter…
Sinovac announced approval of human clinical trial for a vaccine candidate against COVID-19
On Apr. 14, 2020, Sinovac Biotech announced that the Company had obtained approval to conduct a human clinical…
IHME released updated COVID-19 predictions for deaths and hospital use in the European Economic Area
On Apr. 10, 2020, the Institute for Health Metrics and Evaluation (IHME) released updated COVID-19 predictions for deaths…
Pfizer and BioNTech announced details on collaboration to accelerate global COVID-19 vaccine development
On Apr. 9, 2020, Pfizer and BioNTech disclosed additional details of their collaboration to advance candidates from BioNTech’s…
iBio announced signing of agreements with Infectious Disease Research Institute in support of iBio’s SARS-CoV-2 Virus-Like Particle vaccine development
On Apr. 9, 2020, iBio announced the signing of two agreements with the Infectious Disease Research Institute (IDRI)…
![Dynavax donated 10,000 doses of HEPLISAV-Bï¾® [Hepatitis B Vaccine (Recombinant), adjuvanted] vaccine to emergency healthcare providers](https://www.lifesciencehistory.com/wp-content/uploads/2024/05/dynavax_logo-3.png){kind=logo}
Dynavax donated 10,000 doses of HEPLISAV-Bï¾® [Hepatitis B Vaccine (Recombinant), adjuvanted] vaccine to emergency healthcare providers
On Apr. 8, 2020, Dynavax Technologies announced it had donated 10,000 doses of HEPLISAV-B adult vaccine to help…
Novavax identified Coronavirus vaccine candidate; accelerated initiation of first-in-human trial to mid-May
On Apr. 8, 2020, Novavax announced it had identified a coronavirus vaccine candidate, NVX-CoV2373, a stable, prefusion protein…
Pacific Biosciences powers SARS-CoV-2 research at commercial, academic and government labs
On Apr. 8, 2020, Pacific Biosciences announced it is working with commercial, academic and government research teams that…
Queensland University leads international team researching ancient Australian plant to help in production of COVID-19 vaccine
On Apr. 7, 2020, the Queensland University of Technology (QUT) announced that it is leading an international team…
Successful MERS vaccine in mice may hold promise for COVID-19 vaccine
On Apr. 7, 2020, Researchers at the University of Iowa and the University of Georgia announced they had…
OncoSec collaborated with Providence Cancer Institute to conduct first-in-human trial of CORVax12, an Investigational Vaccine to prevent COVID-19
On Apr. 6, 2020, OncoSec Medical announced that Providence Cancer Institute, a part of Providence St. Joseph Health…
New antiviral drug from Emory University heading into clinical trials for COVID-19 treatment
On Apr. 6, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced its participation in a clinical trial…
VGXI supported rapid timeline to clinical testing for Coronavirus vaccine
On Apr. 6, 2020, VGXI, announced it has completed manufacturing and release of a DNA vaccine to combat…
New IHME COVID-19 forecasts find lower hospital bed need, epidemics starting to peak confirms social distancing works
On Apr. 5, 2020, updated COVID-19 estimates from the Institute for Health Metrics and Evaluation (IHME) found that…
ImmunityBio combined supercomputing power with Microsoft Azure to target infection -Doorway of the Coronavirus
On Apr. 1, 2020, ImmunityBio, a privately held immunotherapy company within the NantWorks ecosystem of companies, announced it…
Vaxart provided update on its oral COVID-19 vaccine program
On Mar. 31, 2020, Vaxart announced it had produced five COVID-19 vaccine candidates for testing in its preclinical…
VBI Vaccines announced collaboration with National Research Council of Canada to develop pan-Coronavirus vaccine candidate
On Mar. 31, 2020, VBI Vaccines announced a collaboration with the National Research Council of Canada (NRC) to…
Altimmune and the University of Alabama at Birmingham to collaborate on development of single-dose, intranasal COVID-19 vaccine
On Mar. 30, 2020, Altimmune announced that it had launched a collaboration with the University of Alabama at…
University of Minnesota researchers revealed how the novel coronavirus binds to human cells
On Mar. 30, 2020, researchers from the University of Minnesota broke new ground in understanding how SARS-CoV-2, the…
Johnson & Johnson announced a lead vaccine candidate for COVID-19
On Mar. 30, 2020, Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs…
Biotechnology | COVID-19 | Influenza | Life Science News | Non-Profit Research | Therapeutics | Vaccine
Amyris launched hand sanitizer and receives initial positive result for vaccine adjuvant
On Mar. 27, 2020, Amyris announced that it had completed initial testing of a leading vaccine adjuvant. In…
Atlanta site added to NIH clinical trial of a vaccine for COVID-19
On Mar. 27, 2020, Emory University in Atlanta will begin enrolling healthy adult volunteers ages 18 to 55…
Oxford University COVID-19 vaccine programme opened for clinical trial recruitment
On Mar. 27, 2020, University of Oxford researchers working in an unprecedented vaccine development effort to prevent COVID-19…
Emory University new site in NIH-sponsored coronavirus vaccine study
On Mar. 27, 2020, Emory’s Vaccine and Treatment Evaluation Unit (VTEU) announced participation in a clinical trial testing…
Novartis and life sciences companies commited to fight against COVID-19 with Bill & Melinda Gates Foundation
On Mar. 26, 2020, Novartis and a consortium of life sciences companies announced a collaboration to accelerate the…
Dynavax and CEPI announced collaboration to support effort to develop vaccine for COVID-19
On Mar. 26, 2020, Dynavax and the Coalition for Epidemic Preparedness Innovations (CEPI) announced a collaboration supporting the…
iBio announced advancement of COVID-19 vaccine program
On Mar. 26, 2020, iBio announced that immunization studies for its SARS-CoV-2 Virus-Like Particle program (‘IBIO-200’) were proceeding…
Sartorius Stedim Biotech delivered indispensable biopharma supplies
On Mar. 25, 2020, employees of Sartorius Stedim Biotech in Aubagne, France are keeping production running to ensure…
Biotechnology | COVID-19 | Diagnostics | Life Science News | Medical Device | Medicine | Therapeutics | Vaccine
Life sciences companies commit to fight against COVID-19 pandemic with Bill & Melinda Gates Foundation
On Mar. 25, 2020, a consortium of life sciences companies announced an important collaboration to accelerate the development,…